The innovative partnership is planned to run for several years to develop unique, high value added genomic approaches.
Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and GenoSplice Technology, developers of bioinformatics solutions for analysis of genomic data, today announce they have formed a partnership to combine their expertise.
[…]